Onco-Inmunología Aplicada y Traslacional
O-I Traslacional
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2023
-
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
Science translational medicine, Vol. 15, Núm. 695, pp. eabp9229
-
Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses
Frontiers in Cellular and Infection Microbiology, Vol. 13
2018
-
Immunotherapy targeting 4-1BB: Mechanistic rationale, clinical results, and future strategies
Blood, Vol. 131, Núm. 1, pp. 49-57